Newsbenzinga
Oculis Doses First PIONEER-1 Patient As Privosegtor Advances Into Registrational Testing For Optic Neuritis With FDA SPA Agreement
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…